ストックスクリーナーアプリを入手
25.90
3.72%
0.93
アフターアワーズ：
25.90
Immunovant Inc (IMVT) 最新ニュース
Wolfe Research upgrades Immunovant stock to Outperform on Graves’ disease potential - Investing.com India
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Immunovant, Inc. (NASDAQ: IMVT) - PR Newswire
Wolfe Research Downgrades Immunovant (IMVT) - MSN
(IMVT) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Immunovant (NASDAQ:IMVT) Nasdaq Today Immunology Innovation - Kalkine Media
Immunovant, Inc. (NASDAQ:IMVT) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
How Investors Are Reacting To Immunovant (IMVT) $550 Million Follow-On Equity Raise And Dilution - Sahm
Assenagon Asset Management S.A. Invests $3.31 Million in Immunovant, Inc. $IMVT - MarketBeat
Research Analysts Issue Forecasts for Immunovant Q3 Earnings - MarketBeat
Momentum Shift: How Immunovant Inc. stock responds to policy changesChart Signals & Consistent Income Trade Recommendations - Улправда
How Immunovant Inc. stock compares to growth peers2025 Top Gainers & Technical Confirmation Alerts - Улправда
Squarepoint Ops LLC Has $1.36 Million Stock Position in Immunovant, Inc. $IMVT - MarketBeat
How Immunovant Inc. stock responds to policy changesInflation Watch & Long-Term Safe Return Strategies - ulpravda.ru
Tuyl Christopher Van Sells 10,813 Shares of Immunovant (NASDAQ:IMVT) Stock - MarketBeat
Officer Van Tuyl Acquires 16,676 Of Immunovant Inc [IMVT] - TradingView — Track All Markets
Immunovant Executive Sells Shares to Cover Tax Obligations - TradingView — Track All Markets
First Week of IMVT February 2026 Options Trading - Nasdaq
Can Immunovant Inc. stock weather global recessionPortfolio Growth Summary & Low Drawdown Investment Strategies - DonanımHaber
Is Immunovant Stock a Buy After Roivant Sciences Increased Its Stake by $350 Million? - AOL.com
Is Immunovant Stock a Buy After Roivant Sciences Increased Its Stake by $350 Million? - The Motley Fool
Share Offerings Prompt Huge Insider Buying in These 3 Biotechs - AOL.com
Immunovant (IMVT) Is Up 14.0% After Roivant-Backed $550 Million Equity Raise For IMVT-1402Has The Bull Case Changed? - Yahoo Finance
The Goldman Sachs Group Forecasts Strong Price Appreciation for Immunovant (NASDAQ:IMVT) Stock - MarketBeat
Immunovant (IMVT) Is Up 14.0% After $550 Million Follow-On Backed By Roivant SciencesWhat's Changed - Sahm
Immunovant (IMVT) Stock News and Forecast for Dec. 14, 2025: $550M Financing Closes, Roivant Buys $350M, Analysts Update Targets - ts2.tech
Immunovant (IMVT) down 0.6% since last earnings report: Can it rebound? - MSN
EPS Watch: Why OrthoPediatrics Corp. stock appeals to dividend seekersWeekly Stock Report & Low Drawdown Trading Strategies - moha.gov.vn
Immunovant Raises $550 Million Through Stock Offering - The Globe and Mail
Insider Buying: Sciences Roivant Acquires 16,666,666 Shares of I - GuruFocus
Oppenheimer Maintains Outperform Rating on Immunovant (IMVT) Following Q2 2026 Earnings - MSN
Roivant Sciences buys Immunovant (IMVT) shares worth $349.9m By Investing.com - Investing.com Canada
Roivant Sciences buys Immunovant (IMVT) shares worth $349.9m - Investing.com
Roivant Sciences Ltd. Purchases 16.7 Million Immunovant Shares - TradingView — Track All Markets
Owner Roivant Sciences Ltd Buys 16,666,666 ($350M) Of Immunovant Inc [IMVT] - TradingView — Track All Markets
Immunovant: 'Buy' On Competitive Batoclimab Landscape And IMVT-1402 Advancement - Seeking Alpha
Immunovant Enters Underwriting Agreement for Stock Offering - TradingView — Track All Markets
Immunovant (NASDAQ:IMVT) Stock Price Up 8.1%Here's Why - MarketBeat
Immunovant, Inc. $IMVT is Armistice Capital LLC's 9th Largest Position - MarketBeat
Immunovant drops 7%, prices $550M stock offering - MSN
Immunovant announces $550 million stock offering - MSN
Latham & Watkins Advises on Immunovant’s US$550 Million Offering of Common Stock - Latham & Watkins LLP
Immunovant announces $550 million stock offering and clinical program updates - Investing.com Canada
Roivant Signals Major Pipeline Momentum With Accelerated Timelines - Sahm
Immunovant Announces Roivant President Eric Venker As New CEO: Retail’s Elated - MSN
Immunovant Shares Rise After Pricing $550 Million Stock Offering - marketscreener.com
Immunovant (IMVT) Stock Jumps After $550 Million Share Offering as Graves’ Disease Launch Comes Into Focus - ts2.tech
HighVista Strategies LLC Buys 87,160 Shares of Immunovant, Inc. $IMVT - MarketBeat
Immunovant announces $550 million stock offering and clinical program updates By Investing.com - Investing.com South Africa
Immunovant Announces $550 Million Stock Offering - TipRanks
Immunovant announces pricing of $550 million common stock financing - marketscreener.com
Immunovant Announces Pricing Of $550 Million Common Stock Financing - TradingView — Track All Markets
Immunovant Prices $550 Million Stock Offering - marketscreener.com
Diamond Hill Investment Group, Rhythm Pharmaceuticals, Vail Resorts And Other Big Stocks Moving Higher On Thursday - Benzinga
2.52%
0.07%
大文字化:
|
ボリューム (24 時間):